It is composed of four TAAs that are present on both MHC class I and class II molecules—NY-ESO-1, MAGE-A3, tyrosinase, and TPTE—which express at restricted levels in normal tissues but have a high prevalence and immunogenicity in melanoma. This evidence concerns the gene TYR and melanoma.